Market Overview:
The global active oxygen species assay market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for active oxygen species assays from pharmaceutical and biotechnology companies, academic institutions, clinical laboratories, and cosmetics industry. Additionally, the growing awareness about benefits of using active oxygen species assays is also contributing to the growth of this market. However, lack of skilled professionals is restraining the growth of this market. On the basis of type, ELISA technology accounted for majority share in 2017 and it is expected to maintain its dominance during forecast period. This can be attributed to its advantages such as high sensitivity and specificity over other technologies used for measuring active oxygen species levels. On the basis of application, pharmaceutical and biotechnology companies held major share in 2017 owing to rising demand for drugs & vaccines development across globe coupled with increasing R&D expenditure by these companies on new drug discovery programs .
Product Definition:
Active oxygen species assays are biochemical tests used to measure the levels of active oxygen species in a given sample. Active oxygen species can be harmful to cells, and so measuring their levels can help indicate the level of oxidative stress in a sample. Active oxygen species assays are important for research into oxidative stress and its effects on cells, as well as for diagnosing and treating conditions caused by oxidative stress.
ELISA Technology:
ELISA (enzyme-linked immunosorbent assay) is a technology used for the detection of specific antibodies in biological fluids. It is one of the most commonly employed technologies in clinical laboratories across the globe. ELISA has several applications such as diagnosis of infectious diseases, autoimmune diseases, cancer and other chronic conditions. The technique helps detect low levels of antibodies using a simple procedure at lower costs with higher sensitivity & specificity compared to other techniques available in the market today.
Flow Cytometry Technology:
Flow cytometry is a technique that measures cell properties and characteristics by determining the size, shape, and content of a single cell. It is used for characterizing different types of cells in biological fluids such as blood or urine. The technology has been applied to measure oxygenation level in various active Oxygen Species (AOS) assays over the years; however, there have been very few advancements until now.
Application Insights:
The market is segmented into five applications, which include pharmaceutical and biotechnology companies, academic institutions, clinical laboratories, cosmetics industry and others. The pharmaceutical and biotechnology companies segment dominated the overall market in terms of revenue in 2017. This high share can be attributed to the growing number of product launches by various players in this sector over the past few years. For instance; In April 2016; Cosmo Pharmaceutical Co., Ltd., a Korea-based company launched Caspase Activation Assay for research purposes only which was based on ELISA technology for active oxygen species detection.
In March 2015; Ortho-Clinical Diagnostics Inc.; a U.S.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of key pharmaceutical and biotechnology companies, which are engaged in extensive R&D for new drug development. Moreover, increasing government funding for medical research is also expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising healthcare expenditure by various governments as well as private organizations and an increase in disposable income that has triggered consumer demand for cosmetics products among women aged 25 years & above group. The Middle East & Africa region is estimated to grow at a significant CAGR over the forecast period due to high unmet clinical needs coupled with rapidly growing biotechnology industry especially pertaining cancer research activities supported by government funding agencies such as Saudi Arabia Science Council (SASC) and National Research Foundation (NRF). In addition, increasing investments from public-private partnerships are likely boost this regional market growth further.
Growth Factors:
- Increasing demand for rapid and accurate diagnostic tests
- Rising prevalence of respiratory diseases
- Technological advancements in active oxygen species assays
- Growing number of clinical laboratories and research institutes
- Increasing funding for research on active oxygen species assays
Scope Of The Report
Report Attributes
Report Details
Report Title
Active Oxygen Species Assays Market Research Report
By Type
ELISA Technology, Flow Cytometry Technology, Chromatography Technology
By Application
Pharmaceutical And Biotechnology Companies, Academic Institution, Clinical Laboratory, Cosmetics Industry
By Companies
Abcam plc (U.K.), AMS Biotechnology (U.K.), BioVision, Inc. (U.S.), Cell Biolabs, Inc. (U.S.), Enzo Biochem (U.S.), Merck (U.S.), Oxford Biomedical Research (U.S.), QIAGEN N.V. (Netherlands), Promega Corporation (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific (U.S.)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
178
Number of Tables & Figures
125
Customization Available
Yes, the report can be customized as per your need.
Global Active Oxygen Species Assays Market Report Segments:
The global Active Oxygen Species Assays market is segmented on the basis of:
Types
ELISA Technology, Flow Cytometry Technology, Chromatography Technology
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical And Biotechnology Companies, Academic Institution, Clinical Laboratory, Cosmetics Industry
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abcam plc (U.K.)
- AMS Biotechnology (U.K.)
- BioVision, Inc. (U.S.)
- Cell Biolabs, Inc. (U.S.)
- Enzo Biochem (U.S.)
- Merck (U.S.)
- Oxford Biomedical Research (U.S.)
- QIAGEN N.V. (Netherlands)
- Promega Corporation (U.S.)
- Sigma-Aldrich Corporation (U.S.)
- Thermo Fisher Scientific (U.S.)
Highlights of The Active Oxygen Species Assays Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- ELISA Technology
- Flow Cytometry Technology
- Chromatography Technology
- By Application:
- Pharmaceutical And Biotechnology Companies
- Academic Institution
- Clinical Laboratory
- Cosmetics Industry
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Active Oxygen Species Assays Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Active oxygen species assays are a type of laboratory test used to measure the amount of active oxygen species in a sample. Active oxygen species can play important roles in the body's health and can be harmful if they're produced in high levels.
Some of the major players in the active oxygen species assays market are Abcam plc (U.K.), AMS Biotechnology (U.K.), BioVision, Inc. (U.S.), Cell Biolabs, Inc. (U.S.), Enzo Biochem (U.S.), Merck (U.S.), Oxford Biomedical Research (U.S.), QIAGEN N.V. (Netherlands), Promega Corporation (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific (U.S.).
The active oxygen species assays market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Active Oxygen Species Assays Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Active Oxygen Species Assays Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Active Oxygen Species Assays Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Active Oxygen Species Assays Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Active Oxygen Species Assays Market Size & Forecast, 2018-2028
4.5.1 Active Oxygen Species Assays Market Size and Y-o-Y Growth
4.5.2 Active Oxygen Species Assays Market Absolute $ Opportunity
Chapter 5 Global Active Oxygen Species Assays Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Active Oxygen Species Assays Market Size Forecast by Type
5.2.1 ELISA Technology
5.2.2 Flow Cytometry Technology
5.2.3 Chromatography Technology
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Active Oxygen Species Assays Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Active Oxygen Species Assays Market Size Forecast by Applications
6.2.1 Pharmaceutical And Biotechnology Companies
6.2.2 Academic Institution
6.2.3 Clinical Laboratory
6.2.4 Cosmetics Industry
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Active Oxygen Species Assays Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Active Oxygen Species Assays Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Active Oxygen Species Assays Analysis and Forecast
9.1 Introduction
9.2 North America Active Oxygen Species Assays Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Active Oxygen Species Assays Market Size Forecast by Type
9.6.1 ELISA Technology
9.6.2 Flow Cytometry Technology
9.6.3 Chromatography Technology
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Active Oxygen Species Assays Market Size Forecast by Applications
9.10.1 Pharmaceutical And Biotechnology Companies
9.10.2 Academic Institution
9.10.3 Clinical Laboratory
9.10.4 Cosmetics Industry
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Active Oxygen Species Assays Analysis and Forecast
10.1 Introduction
10.2 Europe Active Oxygen Species Assays Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Active Oxygen Species Assays Market Size Forecast by Type
10.6.1 ELISA Technology
10.6.2 Flow Cytometry Technology
10.6.3 Chromatography Technology
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Active Oxygen Species Assays Market Size Forecast by Applications
10.10.1 Pharmaceutical And Biotechnology Companies
10.10.2 Academic Institution
10.10.3 Clinical Laboratory
10.10.4 Cosmetics Industry
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Active Oxygen Species Assays Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Active Oxygen Species Assays Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Active Oxygen Species Assays Market Size Forecast by Type
11.6.1 ELISA Technology
11.6.2 Flow Cytometry Technology
11.6.3 Chromatography Technology
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Active Oxygen Species Assays Market Size Forecast by Applications
11.10.1 Pharmaceutical And Biotechnology Companies
11.10.2 Academic Institution
11.10.3 Clinical Laboratory
11.10.4 Cosmetics Industry
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Active Oxygen Species Assays Analysis and Forecast
12.1 Introduction
12.2 Latin America Active Oxygen Species Assays Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Active Oxygen Species Assays Market Size Forecast by Type
12.6.1 ELISA Technology
12.6.2 Flow Cytometry Technology
12.6.3 Chromatography Technology
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Active Oxygen Species Assays Market Size Forecast by Applications
12.10.1 Pharmaceutical And Biotechnology Companies
12.10.2 Academic Institution
12.10.3 Clinical Laboratory
12.10.4 Cosmetics Industry
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Active Oxygen Species Assays Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Active Oxygen Species Assays Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Active Oxygen Species Assays Market Size Forecast by Type
13.6.1 ELISA Technology
13.6.2 Flow Cytometry Technology
13.6.3 Chromatography Technology
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Active Oxygen Species Assays Market Size Forecast by Applications
13.10.1 Pharmaceutical And Biotechnology Companies
13.10.2 Academic Institution
13.10.3 Clinical Laboratory
13.10.4 Cosmetics Industry
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Active Oxygen Species Assays Market: Competitive Dashboard
14.2 Global Active Oxygen Species Assays Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abcam plc (U.K.)
14.3.2 AMS Biotechnology (U.K.)
14.3.3 BioVision, Inc. (U.S.)
14.3.4 Cell Biolabs, Inc. (U.S.)
14.3.5 Enzo Biochem (U.S.)
14.3.6 Merck (U.S.)
14.3.7 Oxford Biomedical Research (U.S.)
14.3.8 QIAGEN N.V. (Netherlands)
14.3.9 Promega Corporation (U.S.)
14.3.10 Sigma-Aldrich Corporation (U.S.)
14.3.11 Thermo Fisher Scientific (U.S.)
